This is a Validated Antibody Database (VAD) review about Lymphocyti.. LCMVsSgp2, based on 3 published articles (read how Labome selects the articles), using LCMVsSgp2 antibody in all methods. It is aimed to help Labome visitors find the most suited LCMVsSgp2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Bio X Cell
rat monoclonal (VL-4)
  • immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig 4c
Bio X Cell LCMVsSgp2 antibody (Bio X Cell, VL-4) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 4c). PLoS Pathog (2018) ncbi
rat monoclonal (VL-4)
  • immunohistochemistry - frozen section; Lymphocytic choriomeningitis virus; 1:1000; loading ...; fig 9d
  • flow cytometry; Lymphocytic choriomeningitis virus; loading ...; fig 10d
In order to determine if therapeutic antiviral T cells eliminate viral load in the brain of mice persistently infected from birth with lymphocytic choriomeningitis virus without causing blood-brain barrier breakdown or tissue damage, Bio X Cell LCMVsSgp2 antibody (Bio X Cell, VL-4) was used in immunohistochemistry - frozen section on Lymphocytic choriomeningitis virus samples at 1:1000 (fig 9d) and in flow cytometry on Lymphocytic choriomeningitis virus samples (fig 10d). J Exp Med (2015) ncbi
rat monoclonal (VL-4)
  • immunohistochemistry - frozen section; mouse; 1:1000; fig 5
In order to show how early events during viral infection decide the immune response and facilitate either control, clearance, or persistence of the virus, Bio X Cell LCMVsSgp2 antibody (BioXcell, VL-4) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 5). PLoS Pathog (2015) ncbi
Articles Reviewed
  1. Urata S, Kenyon E, Nayak D, Cubitt B, Kurosaki Y, Yasuda J, et al. BST-2 controls T cell proliferation and exhaustion by shaping the early distribution of a persistent viral infection. PLoS Pathog. 2018;14:e1007172 pubmed publisher
  2. Herz J, Johnson K, McGavern D. Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells. J Exp Med. 2015;212:1153-69 pubmed publisher
  3. Sullivan B, Teijaro J, de la Torre J, Oldstone M. Early virus-host interactions dictate the course of a persistent infection. PLoS Pathog. 2015;11:e1004588 pubmed publisher